Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemolytic Disease of the Newborn”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableAvailableNCT01881334
What this trial is testing

Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants

Who this might be right for
Hematologic MalignanciesInborn Errors of Metabolism DisordersImmune Deficiencies
Joanne Kurtzberg, MD
Not applicableStudy completedNCT04390971
What this trial is testing

Safety and Efficacy Evaluation of ET-01 Transplantation in Subjects With Transfusion Dependent β-Thalassaemia

Who this might be right for
Transfusion Dependent Beta-Thalassaemia
Institute of Hematology & Blood Diseases Hospital, China 3
Not applicableUnknownNCT06072287
What this trial is testing

The Living With a Long-Term Condition Study

Who this might be right for
AsthmaAtrial FibrillationCancer+42 more
King's College London 600
Large-scale testing (Phase 3)Active Not RecruitingNCT05031780
What this trial is testing

A Study Evaluating the Efficacy and Safety of Mitapivat (AG-348) in Participants With Sickle Cell Disease (RISE UP)

Who this might be right for
Sickle Cell Disease
Agios Pharmaceuticals, Inc. 286
Not applicableStudy completedNCT01569971
What this trial is testing

Adolescent, Caregiver, and Young Adult Perspectives of the Transition From Pediatric to Adult Care for Sickle Cell Disease: A Preliminary Evaluation of the Sickle Cell Disease Transition Program

Who this might be right for
Sickle Cell Disease
St. Jude Children's Research Hospital 55
Testing effectiveness (Phase 2)WithdrawnNCT01925001
What this trial is testing

Phase 2 Study of MP4CO to Treat Vaso-occlusive Sickle Crisis

Who this might be right for
Anemia, Sickle CellSickle Cell AnemiaSickle Cell Disease+3 more
Sangart
Large-scale testing (Phase 3)Study completedNCT01825512
What this trial is testing

Efficacy/Safety Study of Deferiprone Compared to Deferasirox in Paediatric Patients

Who this might be right for
Chronic Iron Overload
Consorzio per Valutazioni Biologiche e Farmacologiche 435
Testing effectiveness (Phase 2)UnknownNCT03183375
What this trial is testing

The Efficacy and Safety of HYDROXYUREA in Management of Beta Thalassemia Patients in Karachi Pakistan

Who this might be right for
Thalassemia, Beta
Dr.Saqib Hussain Ansari 100
Large-scale testing (Phase 3)Study completedNCT01849016
What this trial is testing

N-Acetylcysteine in Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 96
Testing effectiveness (Phase 2)Ended earlyNCT04059406
What this trial is testing

Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Sapablursen (Formerly ISIS 702843, IONIS-TMPRSS6-LRx)

Who this might be right for
Beta Thalassemia Intermedia
Ionis Pharmaceuticals, Inc. 29
Testing effectiveness (Phase 2)Ended earlyNCT04474314
What this trial is testing

IMR-687 in Subjects With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Cardurion Pharmaceuticals, Inc. 115
Testing effectiveness (Phase 2)Study completedNCT03492099
What this trial is testing

Assessing the Safety of Buprenorphine in People With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Johns Hopkins University 47
Large-scale testing (Phase 3)UnknownNCT01016093
What this trial is testing

Zoledronic Acid for the Prevention of Bone Loss Post-bone Marrow Transplantation for Thalassemia Major Patients

Who this might be right for
Beta-ThalassemiaBone Marrow Transplantation
Tehran University of Medical Sciences 50
Large-scale testing (Phase 3)Active Not RecruitingNCT05329649
What this trial is testing

Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Severe Sickle Cell Disease (SCD)

Who this might be right for
Sickle Cell DiseaseHydroxyurea FailureHydroxyurea Intolerance+2 more
Vertex Pharmaceuticals Incorporated 13
Large-scale testing (Phase 3)Looking for participantsNCT07656415
What this trial is testing

Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD)

Who this might be right for
Sickle Cell Disease
Agios Pharmaceuticals, Inc. 159
Early research (Phase 1)Ended earlyNCT04925206
What this trial is testing

A Safety and Efficacy Study Evaluating ET-01 in Subjects with Transfusion Dependent Β-Thalassaemia

Who this might be right for
Transfusion Dependent Beta-Thalassaemia
EdiGene (GuangZhou) Inc. 8
Testing effectiveness (Phase 2)Study completedNCT03285178
What this trial is testing

The Effect of IW-1701 (Olinciguat), a Stimulator of Soluble Guanylate Cyclase (sGC), on Patients With Sickle Cell Disease (SCD)

Who this might be right for
Sickle Cell Disease
Cyclerion Therapeutics 88
Post-approval studies (Phase 4)UnknownNCT01323608
What this trial is testing

The Effect of Vitamin D Supplementation on Calcium Excretion in Thalassemia: a Dose Response Study

Who this might be right for
Thalassemia Major
Weill Medical College of Cornell University 40
Early research (Phase 1)Looking for participantsNCT07015684
What this trial is testing

131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)

Who this might be right for
Sickling Disorder Due to Hemoglobin S
Columbia University 24
Not applicableWithdrawnNCT00618644
What this trial is testing

Ranibizumab for Neovascularization in Sickle Cell Retinopathy

Who this might be right for
Sickle Cell AnemiaRetinopathy
Kresge Eye Institute
Next Page